Ikutaro Kumagai
Akita University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ikutaro Kumagai.
Cancer | 1980
Tetsuro Kato; Ryosuke Nemoto; Hisashi Mori; Ikutaro Kumagai
Mitomycin C (MMC) was microencapsulated with ethylcellulose. The microcapsules contained, on average, 80% of biologically active MMC and had a sustained‐release property. The mean particle size was 224 μm so that the microcapsules were readily infused into a canine kidney through arterial catheterization. Ex vivo infusion demonstrated that the microcapsules lodged in the small arteries, mainly at the cortico‐medullary junction, and released concentrated MMC into the surrounding tissue. In vivo experiments revealed that the canine kidneys infused with the microcapsules retained active MMC for more than 6 hours and showed extensive necrosis five days after the infusion. The kidneys infused with nonencapsulated MMC rapidly excreted MMC and showed mild histologic changes. The blood level of MMC released from the intrarenal microcapsules was markedly reduced as compared with control levels. The results suggest that the potential therapeutic effect of intraarterial infusion of MMC microcapsules is a function of embolization and prolonged drug action, and that selective infusion of MMC microcapsules into tumor‐supplying arteries could facilitate intensive topical chemotherapy with minimum systemic side‐effects. Cancer 46:14–21, 1980.
Cancer | 1979
Tetsuro Kato; Ryosuke Nemoto; Tadashi Nishimoto; Ikutaro Kumagai; Kunio Miura
In vitro sensitivity of an established cell line from human urinary bladder cancer to various chemotherapeutic agents was determined by 14C‐leucine incorporation into the target cells. Of 12 drugs tested, Carboquone, Neocarzinostatin, Actinomycin D, Adriamycin, Mitomycin C and Chromomycin A3 produced intensive cytotoxic effects, while Thio‐Tepa, Bleomycin, 5‐Fluorouracil and Vincristine were less cytotoxic. Intravesical instillation of Carboquone, one of the most toxic agents in vitro, resulted in complete or partial tumor remission in 6 of 9 patients with bladder cancer. Prophylactic effects of periodic intravesical Carboquone were also indicated in 7 of 8 patients who had experienced recurring superficial bladder tumors.
The Journal of Urology | 1980
Ikutaro Kumagai; Shigeki Matsuo; Tetsuro Kato
A case is reported of incomplete renal tubular acidosis (type 1) associated with medullary sponge kidney followed by nephrocalcinosis. Although several cases of classic renal tubular acidosis associated with medullary sponge kidney have been documented a case of incomplete renal tubular acidosis associated with medullary sponge kidney seems to be rare. We recommend examination for incomplete renal tubular acidosis in patients with medullary sponge kidney and nephrocalcinosis without systemic acidosis.
The Lancet | 1979
Tetsuro Kato; Ryosuke Nemoto; Hisashi Mori; Ikutaro Kumagai
Tohoku Journal of Experimental Medicine | 1974
Seigi Tsuchida; Ikutaro Kumagai; Kunio Miura; Shigeru Mori
Tohoku Journal of Experimental Medicine | 1978
Seigi Tsuchida; Ikutaro Kumagai
Tohoku Journal of Experimental Medicine | 1978
Seigi Tsuchida; Ikuo Miyagawa; Takashi Harada; Ikutaro Kumagai
The Japanese Journal of Urology | 1975
Ikutaro Kumagai
Tohoku Journal of Experimental Medicine | 1974
Masaaki Kuwahara; Ikutaro Kumagai; Tetsuro Kato; Hisashi Takahashi; Ikuo Miyagawa
The Japanese Journal of Urology | 1980
Tetsuro Kato; Ryosuke Nemoto; Ikutaro Kumagai; Hisashi Mori; Hiromitsu Noto; Kohji Ishida; Ryuichi Chiba; Hiroaki Kato